Predictive Value of the Total Bilirubin and CA50 Screened Based on Machine Learning for Recurrence of Bladder Cancer Patients

References

• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Lin Y, Wang Y, Wu Q, et al. Association between obesity and bladder cancer recurrence: A meta-analysis. Clin Chim Acta. 2018;480:41–46. doi:10.1016/j.cca.2018.01.039
   PubMed Web of Science ®Google Scholar
• Liu C, Xu P, Shao S, et al. The value of urinary exosomal lncRNA SNHG16 as a diagnostic biomarker for bladder cancer. Mol Biol Rep. 2023;50(10):8297–8304. doi:10.1007/s11033-023-08667-z
   PubMed Web of Science ®Google Scholar
• Miyake M, Nishimura N, Ohnishi S, et al. Diagnostic and prognostic roles of Urine Nectin-2 and Nectin-4 in human bladder cancer. Cancers. 2023;15(9):2565. doi:10.3390/cancers15092565
   PubMed Web of Science ®Google Scholar
• Flaig TW, Spiess PE, Abern M, et al. NCCN Guidelines® insights: Bladder cancer, version 2.2022. J Natl Compr Canc Netw. 2022;20(8):866–878. doi:10.6004/jnccn.2022.0041
   PubMed Web of Science ®Google Scholar
• Serafetinidis E, Campos-Juanatey F, Hallscheidt P, et al. Summary paper of the updated 2023 European Association of Urology guidelines on urological trauma. Eur Urol Focus. 2023;13(23):00196.
   Google Scholar
• Hindmarsh JT, Lyon AW. Strategies to promote rational clinical chemistry test utilization. Clin Biochem. 1996;29(4):291–299. doi:10.1016/0009-9120(96)00042-2
   PubMed Web of Science ®Google Scholar
• Zheng HL, Lu J, Xie JW, et al. Exploring the value of new preoperative inflammation prognostic score: white blood cell to hemoglobin for gastric adenocarcinoma patients. BMC Cancer. 2019;19(1):1127. doi:10.1186/s12885-019-6213-0
   PubMed Web of Science ®Google Scholar
• Bongers SH, Chen N, van Grinsven E, et al. Kinetics of neutrophil subsets in acute, subacute, and chronic inflammation. Front Imm. 2021;12:674079. doi:10.3389/fimmu.2021.674079
   PubMed Web of Science ®Google Scholar
• Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Imm. 2018;9:754. doi:10.3389/fimmu.2018.00754
   PubMed Web of Science ®Google Scholar
• Zhang L, Guan Z, Yin Y, et al. Predictive value of indicator of CA125 combined with D-dimer (ICD) for lymph node metastasis in patients with ovarian cancer: a two center cohort study. J Cancer. 2022;13(8):2447–2456. doi:10.7150/jca.70737
   PubMedGoogle Scholar
• Xu R, Wang J, Huang X, et al. Clinical value of spectral CT imaging combined with AFP in identifying liver cancer and hepatic focal nodular hyperplasia. J BUON. 2019;24(4):1429–1434.
   PubMed Web of Science ®Google Scholar
• Moriyama J, Oshima Y, Nanami T, et al. Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer. Surg Today. 2021;51(10):1638–1648. doi:10.1007/s00595-021-02248-y
   PubMed Web of Science ®Google Scholar
• Xia X, Li K, Wu R, et al. Predictive value of neuron-specific enolase, neutrophil-to-lymphocyte-ratio and lymph node metastasis for distant metastasis in small cell lung cancer. Clin Respir J. 2020;14(11):1060–1066. doi:10.1111/crj.13242
   PubMed Web of Science ®Google Scholar
• Tsai IJ, Shen WC, Lee CL, Wang HD, Lin CY. Machine Learning in prediction of bladder cancer on clinical laboratory data. Diagnostics. 2022;12(1):203. doi:10.3390/diagnostics12010203
   Web of Science ®Google Scholar
• Ismail AA. When laboratory tests can mislead even when they appear plausible. Clin Med Lond. 2017;17(4):329–332. doi:10.7861/clinmedicine.17-4-329
   PubMed Web of Science ®Google Scholar
• Saboury B, Morris M, Siegel E. Future directions in artificial intelligence. Radiol Clin North Am. 2021;59(6):1085–1095. doi:10.1016/j.rcl.2021.07.008
   PubMed Web of Science ®Google Scholar
• Stilgoe J. Machine learning, social learning and the governance of self-driving cars. Soc Stud Sci. 2018;48(1):25–56. doi:10.1177/0306312717741687
   PubMed Web of Science ®Google Scholar
• O’Connor S. Open artificial intelligence platforms in nursing education: tools for academic progress or abuse? Nurse Educ Pract. 2023;66:103537. doi:10.1016/j.nepr.2022.103537
   PubMed Web of Science ®Google Scholar
• Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechl J. 2014;13:8–17. doi:10.1016/j.csbj.2014.11.005
   PubMed Web of Science ®Google Scholar
• Cruz JA, Wishart DS. Applications of machine learning in cancer prediction and prognosis. Cancer Inform. 2007;2:59–77.
   PubMedGoogle Scholar
• Banerjee M, Reynolds E, Andersson HB, Nallamothu BK. Tree-Based Analysis. Circ Cardiovasc Qual Out. 2019;12(5):e004879. doi:10.1161/CIRCOUTCOMES.118.004879
   PubMed Web of Science ®Google Scholar
• Nadeem MW, Goh HG, Ponnusamy V, Andonovic I, Khan MA, Hussain M. A fusion-based machine learning approach for the prediction of the onset of diabetes. Healthcare. 2021;9(10):1393. doi:10.3390/healthcare9101393
   Web of Science ®Google Scholar
• Zhong X, Yu J, Jiang F, et al. A risk prediction model based on machine learning for early cognitive impairment in hypertension: development and validation study. Front Public Health. 2023;11:1143019. doi:10.3389/fpubh.2023.1143019
   PubMed Web of Science ®Google Scholar
• Lee J, Choo MS, Yoo S, Cho MC, Son H, Jeong H. Intravesical prostatic protrusion and prognosis of non-muscle invasive bladder cancer: analysis of long-term data over 5 years with machine-learning algorithms. J Clin Med. 2021;10(18):4263. doi:10.3390/jcm10184263
   PubMed Web of Science ®Google Scholar
• Bhambhvani HP, Zamora A, Shkolyar E, et al. Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer. Urol Oncol. 2021;39(3):193.e7–193.e12. doi:10.1016/j.urolonc.2020.05.009
   Web of Science ®Google Scholar
• Goetze OT, Al-Batran SE, Chevallay M, Mönig SP. Multimodal treatment in locally advanced gastric cancer. Updates Surg. 2018;70(2):173–179. doi:10.1007/s13304-018-0539-z
   PubMed Web of Science ®Google Scholar
• Choi W, Ochoa A, McConkey DJ, et al. Genetic alterations in the molecular subtypes of bladder cancer: illustration in the cancer genome atlas dataset. Eur Urol. 2017;72(3):354–365. doi:10.1016/j.eururo.2017.03.010
   PubMed Web of Science ®Google Scholar
• Painuli D, Bhardwaj S, Köse U. Recent advancement in cancer diagnosis using machine learning and deep learning techniques: a comprehensive review. Comput Biol Med. 2022;146:105580. doi:10.1016/j.compbiomed.2022.105580
   PubMed Web of Science ®Google Scholar
• Gaur K, Jagtap MM. Role of artificial intelligence and machine learning in prediction, diagnosis, and prognosis of cancer. Cureus. 2022;14(11):e31008. doi:10.7759/cureus.31008
   PubMed Web of Science ®Google Scholar
• Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoecono. 2003;21(18):1315–1330. doi:10.1007/BF03262330
   PubMed Web of Science ®Google Scholar
• de Kok JB, van Balken MR, Roelofs RW, van Aarssen YA, Swinkels DW, Klein Gunnewiek JM. Quantification of hTERT mRNA and telomerase activity in bladder washings of patients with recurrent urothelial cell carcinomas. Clin Chem. 2000;46(12):2003–2007. doi:10.1093/clinchem/46.12.2003
   PubMed Web of Science ®Google Scholar
• Cao Y, Deng S, Yan L, et al. A nomogram based on pretreatment levels of serum bilirubin and total bile acid levels predicts survival in colorectal cancer patients. BMC Cancer. 2021;21(1):85. doi:10.1186/s12885-021-07805-9
   PubMed Web of Science ®Google Scholar
• Feng L, Gu S, Wang P, et al. Pretreatment values of bilirubin and albumin are not prognostic predictors in patients with advanced pancreatic cancer. Cancer Med. 2018;7(12):5943–5951. doi:10.1002/cam4.1848
   PubMed Web of Science ®Google Scholar
• Geng Y, Mei Y, Xi Y, et al. Bilirubin can be used as a prognostic factor for lung adenocarcinoma patients with EGFR mutations. Onco Targets Ther. 2020;13:11089–11095. doi:10.2147/OTT.S266477
   PubMed Web of Science ®Google Scholar
• Haas M, Heinemann V, Kullmann F, et al. Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy. J Cancer Res Clin Oncol. 2013;139(4):681–689. doi:10.1007/s00432-012-1371-3
   PubMed Web of Science ®Google Scholar
• Liu X, Meng QH, Ye Y, Hildebrandt MA, Gu J, Wu X. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. Carcinogenesis. 2015;36(2):243–248. doi:10.1093/carcin/bgu247
   PubMed Web of Science ®Google Scholar
• Li N, Xu M, Cai MY, et al. Elevated serum bilirubin levels are associated with improved survival in patients with curatively resected non-small-cell lung cancer. Cancer Epidemiol. 2015;39(5):763–768. doi:10.1016/j.canep.2015.06.007
   PubMed Web of Science ®Google Scholar
• Ogłuszka M, Orzechowska M, Jędroszka D, Witas P, Bednarek AK. Evaluate Cutpoints: Adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator. Comput Meth Prog Biomed. 2019;177:133–139. doi:10.1016/j.cmpb.2019.05.023
   PubMed Web of Science ®Google Scholar
• Lindholm L, Holmgren J, Svennerholm L, et al. Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. Int Arch Allergy Appl Imm. 1983;71(2):178–181. doi:10.1159/000233384
   PubMedGoogle Scholar
• Kokociñska D, Jarzab B, Król R, Ziaja K, Szejbak K, Kuśmierski S. A comparison of the clinical usefulness of CA 19-9 and CA 50 in the diagnosis and monitoring of gastrointestinal cancers. J Environ Pathol Toxicol Oncol. 1996;15(2–4).
   Google Scholar
• Shan M, Tian Q, Zhang L. Serum CA50 levels in patients with cancers and other diseases. Prog Mol Biol Transl Sci. 2019;162:187–198.
   PubMed Web of Science ®Google Scholar
• Luang S, Teeravirote K, Saentaweesuk W, Ma-In P, Silsirivanit A. Carbohydrate Antigen 50: values for diagnosis and prognostic prediction of intrahepatic cholangiocarcinoma. Medicina. 2020;56(11):616. doi:10.3390/medicina56110616
   PubMedGoogle Scholar
• Lei XF, Jia SZ, Ye J, et al. Application values of detection of serum CA199, CA242 and CA50 in the diagnosis of pancreatic cancer. J Biol Regul Homeost Agents. 2017;31(2):383–388.
   PubMed Web of Science ®Google Scholar
• Li Q, Dai W, Li Y, Xu Y, Li X, Cai S. Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection. Sci Rep. 2017;7:46345. doi:10.1038/srep46345
   PubMed Web of Science ®Google Scholar